|
 |
|
|||||||
|
|||||||||
Diabetes 51:1884-1888, 2002
© 2002 by the American Diabetes Association, Inc.
Plasma Adiponectin Concentration Is Associated With Skeletal Muscle Insulin Receptor Tyrosine Phosphorylation, and Low Plasma Concentration Precedes a Decrease in Whole-Body Insulin Sensitivity in Humans
1 Clinical Diabetes and Nutrition Section, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Phoenix, Arizona
2 Department of Internal Medicine and Molecular Science, Graduate School of Medicine, Osaka University, Osaka, Japan
3 Department of Medicine, Division of Diabetes and Endocrine Research, Mount Zion Medical Center, University of California, San Francisco, California
4 Department of Nutrition, University of California, Davis, California
Adiponectin, the most abundant adipose-specific protein, has been found to be negatively associated with degree of adiposity and positively associated with insulin sensitivity in Pima Indians and other populations. Moreover, adiponectin administration to rodents has been shown to increase insulin-induced tyrosine phosphorylation of the insulin receptor (IR) and also increase whole-body insulin sensitivity. To further characterize the relationship between plasma adiponectin concentration and insulin sensitivity in humans, we examined 1) the cross-sectional association between plasma adiponectin concentration and skeletal muscle IR tyrosine phosphorylation and 2) the prospective effect of plasma adiponectin concentration at baseline on change in insulin sensitivity. Fasting plasma adiponectin concentration, body composition (hydrodensitometry or dual energy X-ray absorptiometry), insulin sensitivity (insulin-stimulated glucose disposal, hyperinsulinemic clamp), and glucose tolerance (75-g oral glucose tolerance test) were measured in 55 Pima Indians (47 men and 8 women, aged 31 ± 8 years, body fat 29 ± 8% [mean ± SD]; 50 with normal glucose tolerance, 3 with impaired glucose tolerance, and 2 with diabetes). Group 1 (19 subjects) underwent skeletal muscle biopsies for the measurement of basal and insulin-stimulated tyrosine phosphorylation of the IR (stimulated by 100 nmol/l insulin). The fold increase after insulin stimulation was calculated as the ratio between maximal and basal phosphorylation. Group 2 (38 subjects) had follow-up measurements of insulin-stimulated glucose disposal. Cross-sectionally, plasma adiponectin concentration was positively associated with insulin-stimulated glucose disposal (r = 0.58, P < 0.0001) and negatively associated with percent body fat (r = -0.62, P < 0.0001) in the whole group. In group 1 plasma adiponectin was negatively associated with the basal (r = -0.65, P = 0.003) and positively associated with the fold increase in IR tyrosine phosphorylation (r = 0.69, P = 0.001) before and after the adjustment for percent body fat (r = -0.58, P = 0.01 and r = 0.54, P = 0.02, respectively). Longitudinally, after adjustment for age, sex, and percent body fat, low plasma adiponectin concentration at baseline was associated with a decrease in insulin sensitivity (P = 0.04). In conclusion, our cross-sectional data suggest a role of physiological concentration of fasting plasma adiponectin in the regulation of skeletal muscle IR tyrosine phosphorylation. Prospectively, low plasma adiponectin concentration at baseline precedes a decrease in insulin sensitivity. Our data indicate that adiponectin plays an important role in regulation of insulin sensitivity in humans.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Hojlund, D. Glintborg, N. R. Andersen, J. B. Birk, J. T. Treebak, C. Frosig, H. Beck-Nielsen, and J. F.P. Wojtaszewski Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment Diabetes, February 1, 2008; 57(2): 357 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Liu, M. Grifman, J. Macdonald, P. Moller, F. Wong-Staal, and Q.-X. Li Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase J. Endocrinol., September 1, 2007; 194(3): 569 - 578. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Barb, C. J Williams, A. K Neuwirth, and C. S Mantzoros Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 858S - 866S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cesari, K. Narkiewicz, R. De Toni, E. Aldighieri, C. J. Williams, and G. P. Rossi Heritability of Plasma Adiponectin Levels and Body Mass Index in Twins J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3082 - 3088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Kowalska, M. Straczkowski, A. Nikolajuk, A. Adamska, M. Karczewska-Kupczewska, E. Otziomek, S. Wolczynski, and M. Gorska Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome Hum. Reprod., July 1, 2007; 22(7): 1824 - 1829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. G. Hanley, D. Bowden, L. E. Wagenknecht, A. Balasubramanyam, C. Langfeld, M. F. Saad, J. I. Rotter, X. Guo, Y.-D. I. Chen, M. Bryer-Ash, et al. Associations of Adiponectin with Body Fat Distribution and Insulin Sensitivity in Nondiabetic Hispanics and African-Americans J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2665 - 2671. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Tomoda, M. Yoshikawa, T. Itoh, S. Tamaki, A. Fukuoka, K. Komeda, and H. Kimura Elevated Circulating Plasma Adiponectin in Underweight Patients With COPD Chest, July 1, 2007; 132(1): 135 - 140. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W.-S. Chow, B. M.Y. Cheung, A. W.K. Tso, A. Xu, N. M.S. Wat, C. H.Y. Fong, L. H.Y. Ong, S. Tam, K. C.B. Tan, E. D. Janus, et al. Hypoadiponectinemia as a Predictor for the Development of Hypertension: A 5-Year Prospective Study Hypertension, June 1, 2007; 49(6): 1455 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Majuri, M Santaniemi, K Rautio, A Kunnari, J Vartiainen, A Ruokonen, Y A Kesaniemi, J S Tapanainen, O Ukkola, and L Morin-Papunen Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study Eur. J. Endocrinol., February 1, 2007; 156(2): 263 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Yamaza, T. Komatsu, K. To, H. Toyama, T. Chiba, Y. Higami, and I. Shimokawa Involvement of Insulin-Like Growth Factor-1 in the Effect of Caloric Restriction: Regulation of Plasma Adiponectin and Leptin J. Gerontol. A Biol. Sci. Med. Sci., January 1, 2007; 62(1): 27 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Wolk and V. K. Somers Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Sleep and the metabolic syndrome Exp Physiol, January 1, 2007; 92(1): 67 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Ategbo, O. Grissa, A. Yessoufou, A. Hichami, K. L. Dramane, K. Moutairou, A. Miled, A. Grissa, M. Jerbi, Z. Tabka, et al. Modulation of Adipokines and Cytokines in Gestational Diabetes and Macrosomia J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4137 - 4143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Damjanovic, N. M. Lalic, P. M. Pesko, M. S. Petakov, A. Jotic, D. Miljic, K. S. Lalic, L. Lukic, M. Djurovic, and V. B. Djukic Acute Effects of Ghrelin on Insulin Secretion and Glucose Disposal Rate in Gastrectomized Patients J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2574 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Ong, J. Frystyk, A. Flyvbjerg, C. J. Petry, the Avon Longitudinal Study of Parents and Childre, A. Ness, and D. B. Dunger Sex-Discordant Associations With Adiponectin Levels and Lipid Profiles in Children. Diabetes, May 1, 2006; 55(5): 1337 - 1341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Knobler, M. Benderly, V. Boyko, S. Behar, Z. Matas, A. Rubinstein, I. Raz, and J. Wainstein Adiponectin and the development of diabetes in patients with coronary artery disease and impaired fasting glucose Eur. J. Endocrinol., January 1, 2006; 154(1): 87 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Jang, J. H. Lee, J. S. Chae, O. Y. Kim, S. J. Koh, J. Y. Kim, H. Cho, J. E. Lee, and J. M Ordovas Association of the 276G->T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans Am. J. Clinical Nutrition, October 1, 2005; 82(4): 760 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Berggren, M. W. Hulver, and J. A. Houmard Fat as an endocrine organ: influence of exercise J Appl Physiol, August 1, 2005; 99(2): 757 - 764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Zhang, H. Holt, C. Wang, O. H. Hadid, and C. D. Byrne Expression of AdipoR1 In Vivo in Skeletal Muscle Is Independently Associated With Measures of Truncal Obesity in Middle-Aged Caucasian Men Diabetes Care, August 1, 2005; 28(8): 2058 - 2060. [Full Text] [PDF]
|
|
|
|
|
|
C. S. Mantzoros, T. Li, J. E. Manson, J. B. Meigs, and F. B. Hu Circulating Adiponectin Levels Are Associated with Better Glycemic Control, More Favorable Lipid Profile, and Reduced Inflammation in Women with Type 2 Diabetes J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4542 - 4548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E Carmina, F Orio, S Palomba, T Cascella, R A Longo, A M Colao, G Lombardi, and R A Lobo Evidence for altered adipocyte function in polycystic ovary syndrome Eur. J. Endocrinol., March 1, 2005; 152(3): 389 - 394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Choi, K. W. Lee, S. G. Kim, N. H. Kim, C. G. Park, H. S. Seo, D. J. Oh, D. S. Choi, and S. H. Baik Inflammation, Insulin Resistance, and Glucose Intolerance in Acute Myocardial Infarction Patients without a Previous Diagnosis of Diabetes Mellitus J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 175 - 180. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Vozarova de Courten, R. L. Hanson, T. Funahashi, R. S. Lindsay, Y. Matsuzawa, S. Tanaka, F. Thameem, J. D. Gruber, P. Froguel, and J. K. Wolford Common Polymorphisms in the Adiponectin Gene ACDC Are Not Associated With Diabetes in Pima Indians Diabetes, January 1, 2005; 54(1): 284 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Salmenniemi, E. Ruotsalainen, J. Pihlajamaki, I. Vauhkonen, S. Kainulainen, K. Punnonen, E. Vanninen, and M. Laakso Multiple Abnormalities in Glucose and Energy Metabolism and Coordinated Changes in Levels of Adiponectin, Cytokines, and Adhesion Molecules in Subjects With Metabolic Syndrome Circulation, December 21, 2004; 110(25): 3842 - 3848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. S.-L. Lam, A. Xu, K. C.-B. Tan, L.-C. Wong, S.-C. Tiu, and S. Tam Serum Adiponectin Is Reduced in Acromegaly and Normalized after Correction of Growth Hormone Excess J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5448 - 5453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L.-M. Chuang, Y.-F. Chiu, W. H.-H. Sheu, Y.-J. Hung, L.-T. Ho, J. Grove, B. Rodriguez, T. Quertermous, Y.-D. I. Chen, C. A. Hsiung, et al. Biethnic Comparisons of Autosomal Genomic Scan for Loci Linked to Plasma Adiponectin in Populations of Chinese and Japanese Origin J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5772 - 5778. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Shetty, P. A. Economides, E. S. Horton, C. S. Mantzoros, and A. Veves Circulating Adiponectin and Resistin Levels in Relation to Metabolic Factors, Inflammatory Markers, and Vascular Reactivity in Diabetic Patients and Subjects at Risk for Diabetes Diabetes Care, October 1, 2004; 27(10): 2450 - 2457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Meier and A. M. Gressner Endocrine Regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin, and Resistin Clin. Chem., September 1, 2004; 50(9): 1511 - 1525. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Kajantie, T. Hytinantti, P. Hovi, and S. Andersson Cord Plasma Adiponectin: A 20-Fold Rise between 24 Weeks Gestation and Term J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4031 - 4036. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bacci, C. Menzaghi, T. Ercolino, X. Ma, A. Rauseo, L. Salvemini, C. Vigna, R. Fanelli, U. Di Mario, A. Doria, et al. The +276 G/T Single Nucleotide Polymorphism of the Adiponectin Gene Is Associated With Coronary Artery Disease in Type 2 Diabetic Patients Diabetes Care, August 1, 2004; 27(8): 2015 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Winzer, O. Wagner, A. Festa, B. Schneider, M. Roden, D. Bancher-Todesca, G. Pacini, T. Funahashi, and A. Kautzky-Willer Plasma Adiponectin, Insulin Sensitivity, and Subclinical Inflammation in Women With Prior Gestational Diabetes Mellitus Diabetes Care, July 1, 2004; 27(7): 1721 - 1727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Tonelli, W. Li, P. Kishore, U. B. Pajvani, E. Kwon, C. Weaver, P. E. Scherer, and M. Hawkins Mechanisms of Early Insulin-Sensitizing Effects of Thiazolidinediones in Type 2 Diabetes Diabetes, June 1, 2004; 53(6): 1621 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Vozarova de Courten, M. Degawa-Yamauchi, R. V. Considine, and P. A. Tataranni High Serum Resistin Is Associated With an Increase in Adiposity But Not a Worsening of Insulin Resistance in Pima Indians Diabetes, May 1, 2004; 53(5): 1279 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mantzoros, E. Petridou, N. Dessypris, C. Chavelas, M. Dalamaga, D. M. Alexe, Y. Papadiamantis, C. Markopoulos, E. Spanos, G. Chrousos, et al. Adiponectin and Breast Cancer Risk J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1102 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Fernandez-Real, A. Castro, G. Vazquez, R. Casamitjana, A. Lopez-Bermejo, G. Penarroja, and W. Ricart Adiponectin Is Associated With Vascular Function Independent of Insulin Sensitivity Diabetes Care, March 1, 2004; 27(3): 739 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bacha, R. Saad, N. Gungor, and S. A. Arslanian Adiponectin in Youth: Relationship to visceral adiposity, insulin sensitivity, and {beta}-cell function Diabetes Care, February 1, 2004; 27(2): 547 - 552. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Havel Update on Adipocyte Hormones: Regulation of Energy Balance and Carbohydrate/Lipid Metabolism Diabetes, February 1, 2004; 53(90001): S143 - 151. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Yamamoto, H. Hirose, I. Saito, K. Nishikai, and T. Saruta Adiponectin, an Adipocyte-Derived Protein, Predicts Future Insulin Resistance: Two-Year Follow-Up Study in Japanese Population J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 87 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bajaj, S. Suraamornkul, P. Piper, L. J. Hardies, L. Glass, E. Cersosimo, T. Pratipanawatr, Y. Miyazaki, and R. A. DeFronzo Decreased Plasma Adiponectin Concentrations Are Closely Related to Hepatic Fat Content and Hepatic Insulin Resistance in Pioglitazone-Treated Type 2 Diabetic Patients J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 200 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Matsuzawa, T. Funahashi, S. Kihara, and I. Shimomura Adiponectin and Metabolic Syndrome Arterioscler. Thromb. Vasc. Biol., January 1, 2004; 24(1): 29 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.G. Hanley, P. W. Connelly, S. B. Harris, and B. Zinman Adiponectin in a Native Canadian Population Experiencing Rapid Epidemiological Transition Diabetes Care, December 1, 2003; 26(12): 3219 - 3225. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Stefan, M. Stumvoll, B. Vozarova, C. Weyer, T. Funahashi, Y. Matsuzawa, C. Bogardus, and P. A. Tataranni Plasma Adiponectin and Endogenous Glucose Production in Humans Diabetes Care, December 1, 2003; 26(12): 3315 - 3319. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gavrila, J. L. Chan, N. Yiannakouris, M. Kontogianni, L. C. Miller, C. Orlova, and C. S. Mantzoros Serum Adiponectin Levels Are Inversely Associated with Overall and Central Fat Distribution but Are Not Directly Regulated by Acute Fasting or Leptin Administration in Humans: Cross-Sectional and Interventional Studies J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4823 - 4831. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chandran, S. A. Phillips, T. Ciaraldi, and R. R. Henry Adiponectin: More Than Just Another Fat Cell Hormone? Diabetes Care, August 1, 2003; 26(8): 2442 - 2450. [Full Text] [PDF]
|
|
|
|
|
|
M. Daimon, T. Oizumi, T. Saitoh, W. Kameda, A. Hirata, H. Yamaguchi, H. Ohnuma, M. Igarashi, M. Tominaga, and T. Kato Decreased Serum Levels of Adiponectin Are a Risk Factor for the Progression to Type 2 Diabetes in the Japanese Population: The Funagata study Diabetes Care, July 1, 2003; 26(7): 2015 - 2020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Fernandez-Real, A. Lopez-Bermejo, R. Casamitjana, and W. Ricart Novel Interactions of Adiponectin with the Endocrine System and Inflammatory Parameters J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2714 - 2718. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gavrila, C.-K. Peng, J. L. Chan, J. E. Mietus, A. L. Goldberger, and C. S. Mantzoros Diurnal and Ultradian Dynamics of Serum Adiponectin in Healthy Men: Comparison with Leptin, Circulating Soluble Leptin Receptor, and Cortisol Patterns J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2838 - 2843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Wu, H. Motoshima, K. Mahadev, T. J. Stalker, R. Scalia, and B. J. Goldstein Involvement of AMP-Activated Protein Kinase in Glucose Uptake Stimulated by the Globular Domain of Adiponectin in Primary Rat Adipocytes Diabetes, June 1, 2003; 52(6): 1355 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Faraj, P. J. Havel, S. Phelis, D. Blank, A. D. Sniderman, and K. Cianflone Plasma Acylation-Stimulating Protein, Adiponectin, Leptin, and Ghrelin before and after Weight Loss Induced by Gastric Bypass Surgery in Morbidly Obese Subjects J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1594 - 1602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Engeli, M. Feldpausch, K. Gorzelniak, F. Hartwig, U. Heintze, J. Janke, M. Mohlig, A. F.H. Pfeiffer, F. C. Luft, and A. M. Sharma Association Between Adiponectin and Mediators of Inflammation in Obese Women Diabetes, April 1, 2003; 52(4): 942 - 947. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Tschritter, A. Fritsche, C. Thamer, M. Haap, F. Shirkavand, S. Rahe, H. Staiger, E. Maerker, H. Haring, and M. Stumvoll Plasma Adiponectin Concentrations Predict Insulin Sensitivity of Both Glucose and Lipid Metabolism Diabetes, February 1, 2003; 52(2): 239 - 243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Hegele, M. E. Kraw, M. R. Ban, B. A. Miskie, M. W. Huff, and H. Cao Elevated Serum C-Reactive Protein and Free Fatty Acids Among Nondiabetic Carriers of Missense Mutations in the Gene Encoding Lamin A/C (LMNA) With Partial Lipodystrophy Arterioscler. Thromb. Vasc. Biol., January 1, 2003; 23(1): 111 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Stefan, J. C. Bunt, A. D. Salbe, T. Funahashi, Y. Matsuzawa, and P. A. Tataranni Plasma Adiponectin Concentrations in Children: Relationships with Obesity and Insulinemia J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4652 - 4656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|